Juan C. Jaen - Net Worth and Insider Trading

Juan C. Jaen Net Worth

The estimated net worth of Juan C. Jaen is at least $25 Million dollars as of 2024-04-25. Juan C. Jaen is the President of Arcus Biosciences Inc and owns about 1,529,708 shares of Arcus Biosciences Inc (RCUS) stock worth over $24 Million. Juan C. Jaen is also the SVP, Drug Discovery & CSO of ChemoCentryx Inc and owns about 30,000 shares of ChemoCentryx Inc (CCXI) stock worth over $2 Million. Details can be seen in Juan C. Jaen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Juan C. Jaen has not made any transactions after 2024-02-27 and currently still holds the listed stock(s).

Transaction Summary of Juan C. Jaen

To

Juan C. Jaen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Juan C. Jaen owns 2 companies in total, including Arcus Biosciences Inc () , and ChemoCentryx Inc () .

Click here to see the complete history of Juan C. Jaen’s form 4 insider trades.

Insider Ownership Summary of Juan C. Jaen

Ticker Comapny Transaction Date Type of Owner
Arcus Biosciences Inc 2024-02-27 director & 10 percent owner & President
ChemoCentryx Inc 2013-03-08 SVP & Drug Discovery & CSO

Juan C. Jaen Latest Holdings Summary

Juan C. Jaen currently owns a total of 2 stocks. Among these stocks, Juan C. Jaen owns 1,529,708 shares of Arcus Biosciences Inc (RCUS) as of February 27, 2024, with a value of $24 Million and a weighting of 93.8%. Juan C. Jaen also owns 30,000 shares of ChemoCentryx Inc (CCXI) as of March 8, 2013, with a value of $2 Million and a weighting of 6.2%.

Latest Holdings of Juan C. Jaen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RCUS Arcus Biosciences Inc 2024-02-27 1,529,708 15.43 23,603,394
CCXI ChemoCentryx Inc 2013-03-08 30,000 51.99 1,559,700

Holding Weightings of Juan C. Jaen


Juan C. Jaen Form 4 Trading Tracker

According to the SEC Form 4 filings, Juan C. Jaen has made a total of 8 transactions in Arcus Biosciences Inc (RCUS) over the past 5 years, including 2 buys and 6 sells. The most-recent trade in Arcus Biosciences Inc is the sale of 27,032 shares on February 27, 2024, which brought Juan C. Jaen around $543,073.

According to the SEC Form 4 filings, Juan C. Jaen has made a total of 0 transactions in ChemoCentryx Inc (CCXI) over the past 5 years. The most-recent trade in ChemoCentryx Inc is the sale of 2,795 shares on March 8, 2013, which brought Juan C. Jaen around $39,046.

Insider Trading History of Juan C. Jaen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Juan C. Jaen Trading Performance

GuruFocus tracks the stock performance after each of Juan C. Jaen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Juan C. Jaen is 3.82%. GuruFocus also compares Juan C. Jaen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Juan C. Jaen within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Juan C. Jaen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Juan C. Jaen

Average Return

78.56%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.65 3.82 1.8 78.56 46.6 40.27
Relative Return to S&P 500(%) 6.34 2.62 -4.38 71 34.07 25.71

Juan C. Jaen Ownership Network

Ownership Network List of Juan C. Jaen

No Data

Ownership Network Relation of Juan C. Jaen


Juan C. Jaen Owned Company Details

What does Arcus Biosciences Inc do?

Who are the key executives at Arcus Biosciences Inc?

Juan C. Jaen is the director & 10 percent owner & President of Arcus Biosciences Inc. Other key executives at Arcus Biosciences Inc include See Remarks Jennifer Jarrett , 10 percent owner Gilead Sciences Inc , and Chief Financial Officer Goeltz Ii Robert C. .

Arcus Biosciences Inc () Insider Trades Summary

Over the past 18 months, Juan C. Jaen made 3 insider transaction in Arcus Biosciences Inc () with a net sale of 38,443. Other recent insider transactions involving Arcus Biosciences Inc () include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 8,506 shares made by Goeltz Ii Robert C. , and a net purchase of 16,248,095 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 110,657 shares of Arcus Biosciences Inc () in total and bought 15,238,095 shares, with a net purchase of 15,127,438 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc () were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.

Arcus Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcus Biosciences Inc Insider Transactions

No Available Data

Juan C. Jaen Mailing Address

Above is the net worth, insider trading, and ownership report for Juan C. Jaen. You might contact Juan C. Jaen via mailing address: 850 Maude Avenue, Mountain View Ca 94043.

Discussions on Juan C. Jaen

No discussions yet.